In contrast, decreased expression of NTNG1/G2 was found to be an independent risk factor for poor survival prognosis in both overall survival (OS) and progression-free survival (PFS) among ccRCC patients. The gene discussed is NTNG1; the disease is nonpapillary renal cell carcinoma.